3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Primary Myelofibrosis
4
Leukemia, Myeloid, Acute
4
Myelodysplastic Syndromes
3
Polycythemia Vera
2
Neoplasms
2
Myeloproliferative Disorders
2
Leukemia
2
Graft vs Host Disease
2
Thrombocythemia, Essential
1
Thalassemia
1
Preleukemia
1
Precancerous Conditions
1
Neoplasms by Histologic Type
1
Myelodysplastic-Myeloproliferative Diseases
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, B-Cell
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Immunoblastic Lymphadenopathy
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Glioma
1
Glioblastoma
1
Carcinoma, Non-Small-Cell Lung
1
Bronchiolitis Obliterans Syndrome
1
Bone Marrow Diseases
1
Interventions
Cyclophosphamide
11
fludarabine phosphate
8
Nivolumab
8
pembrolizumab
7
fludarabine
7
Mycophenolic Acid
6
Magnetic Resonance Spectroscopy
6
Filgrastim
6
Doxorubicin
6
Dacarbazine
6
Brentuximab Vedotin
6
Whole-Body Irradiation
5
Vinblastine
5
Granulocyte Colony-Stimulating Factor
5
Cyclosporine
5
Specimen Handling
4
Melphalan
4
Etoposide
4
Busulfan
4
pegfilgrastim
3
Tacrolimus
3
Radiotherapy
3
Thiotepa
2
Sirolimus
2
Radiation
2
Peripheral Blood Stem Cell Transplantation
2
Fluorodeoxyglucose F18
2
Cyclosporins
2
Clofarabine
2
Azacitidine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
ruxolitinib
×
30 days
×
Clear all
No trials found.